Therapeutic Potential of Graphene Nanoparticles in Breast Cancer: Insights from the Past Ten Years

Keywords: breast cancer, graphene polymers, nanostructure, nanotubes

Abstract

Abstract Views: 0

Breast cancer is the second leading cause of death in women all over the world and its prevention is still a challenge. There are various systemic and local therapies used in the treatment of breast cancer. These therapies, including chemotherapy, endocrine treatment, and tissue-targeted therapies, complement definitive local treatments including surgery or radiation, leading to a significant reduction in both cancer recurrence and disease-related mortality. However, traditional cancer therapies are limited in their specificity and systemic toxicity. In this scenario, nanomaterials may prove to be valuable in providing effective cancer treatments, while reducing unwanted side effects and providing precise diagnosis. Graphene nanoparticles and its derivative reduced graphene oxides (RGO), which belong to a category of carbon nanomaterial, have captured significant interest for their matchless utility as fundamental components in breast cancer treatment. This review focuses on different types of graphene-based nanomaterials which exhibit significant potential in drug delivery applications due to their unique properties, including high drug-loading capacity, pH-dependent release, and enhanced cellular uptake. A thorough search of a bibliographic database during the last decade (2013-2023), was conducted to find the research articles focused on nanotechnology using graphene for cancer treatments to gather the relevant information.

Downloads

Download data is not yet available.

References

Casais-Molina ML, Cab C, Canto G, Medina J, Tapia A. Carbon nanomaterials for breast cancer treatment. J Nanomater. 2018:e058613,. https://doi.org/10.1155/2018/2058613

Jafarizad A, Aghanejad A, Sevim M, et al. Gold nanoparticles and reduced graphene oxide–gold nanoparticle composite materials as covalent drug delivery systems for breast cancer treatment. ChemistrySelect. 2017;2(23):6663-6672. https://doi.org/10.1002/slct.201701178

Saeed AA, Sánchez JLA, O'Sullivan CK, Abbas MN. DNA biosensors based on gold nanoparticle-modified graphene oxide for the detection of breast cancer biomarkers for early diagnosis. Bioelectrochem. 2017;118:91–99. https://doi.org/10.1016/j.bioelechem.2017.07.002

Behbudi G. Mini review of graphene oxide for medical detection and applications. J Adv Appl NanoBio Tech. 2020;1(3):63–66. https://doi.org/10.47277/AANBT/1(3)66

Masoumzade R, Behbudi G, Mazraedoost S. A medical encyclopedia with new approach: Graphene quantum dots for anti-breast cancer applications—mini review. Adv Appl NanoBio-Technol. 2020;1(4):84–90.

Zheng J, Meng D, Zheng X, Zhang Y, Chen HF. Graphene-based materials: A new tool to fight against breast cancer. Int J Pharm. 2021;603:e120644. https://doi.org/10.1016/j.ijpharm.2021.120644

Diaz-Diestra D, Thapa B, Badillo-Diaz D, Beltran-Huarac J, Morell G, Weiner BR. Graphene oxide/ZnS:Mn nanocomposite functionalized with folic acid as a non-toxic and effective theranostic platform for breast cancer treatment. Nanomaterials. 2018;8(7):e484. https://doi.org/10.3390/nano8070484

Astani S, Salehi R, Massoumi B, Massoudi A. Co-delivery of cisplatin and doxorubicin by carboxylic acid functionalized poly(hydroxyethyl methacrylate)/reduced graphene nanocomposite for combination chemotherapy of breast cancer cells. J Biomater Sci Polym Ed. 2021;32(5):657–677. https://doi.org/10.1080/09205063.2020.1855393

Ebrahimi M, Pooladi M. The synergistic anti-cancer traits of graphene oxide plus doxorubicin against BT474 and MCF7 breast cancer stem cells in vitro. Appl Biochem Biotechnol. 2021;193:3586–3601. https://doi.org/10.1007/s12010-021-03623-8

Shahidi M, Haghiralsadat BF, Abazari O, et al. HB5 aptamer-tagged graphene oxide for co-delivery of doxorubicin and silibinin, and highly effective combination therapy in breast cancer. Cancer Nano. 2023;14:e59. https://doi.org/10.1186/s12645-023-00212-8

Giusto E, Žárská L, Beirne DF, et al. Graphene oxide nanoplatforms to enhance cisplatin-based drug delivery in anti-cancer therapy. Nanomaterials. 2022;12(14):e2372. https://doi.org/10.3390/nano12142372

Matiyani M, Rana A, Pal M, Dokwal S, Sahoo NG. Polyamidoamine dendrimer decorated graphene oxide as a pH-sensitive nanocarrier for the delivery of hydrophobic anti-cancer drug quercetin: a remedy for breast cancer. J Pharm Pharmacol. 2023;75(6):859–872. https://doi.org/10.1093/jpp/rgad036

Vallejo MJ, Salazar L, Grijalva M. Oxidative stress modulation and ROS-mediated toxicity in cancer: A review on in vitro models for plant-derived compounds. Oxid Med Cell Longev. 2017;2017:e4586068. https://doi.org/10.1155/2017/4586068

Rajeev MR, Manjusha V, Anirudhan TS. Transdermal delivery of doxorubicin and methotrexate from polyelectrolyte three-layer nanoparticle of graphene oxide/polyethyleneimine/dextran sulphate for chemotherapy: In vitro and in vivo studies. Chem Eng J. 2023;466:e143244. https://doi.org/10.1016/j.cej.2023.143244

Li Q, Wen J, Liu C, et al. Graphene-nanoparticle-based self-healing hydrogel in preventing postoperative recurrence of breast cancer. ACS Biomater Sci Eng. 2019;5(2):768–779. https://doi.org/10.1021/acsbiomaterials.8b01475

Centane S, Nyokong T. Co phthalocyanine mediated electrochemical detection of the HER2 in the presence of Au and CeO₂ nanoparticles and graphene quantum dots. Bioelectrochemistry. 2023;149:e108301. https://doi.org/10.1016/j.bioelechem.2022.108301

Mohammadpour-Haratbar A, Boraei SBA, Zare Y, Rhee KY, Park SJ. Graphene-based electrochemical biosensors for breast cancer detection. Biosensors. 2023;13(1):e80. https://doi.org/10.3390/bios13010080

Kutwin M, Sawosz E, Jaworski S, et al. Nanocomplexes of graphene oxide and platinum nanoparticles against various human cancer cell lines. Materials. 2019;12(6):e909. https://doi.org/10.3390/ma12060909

Joze-Majidi H, Zabihi E, Arab-Bafrani Z, Mir SM, Reiter RJ. Comparative radiosensitization efficiency assessment of graphene oxide and Ti₃C₂ MXene as 2D carbon-based nanoparticles against breast cancer cells: characterization, toxicity and mechanisms. 2D Mater. 2023;10(2):e025021. http://dx.doi.org/10.1088/2053-1583/acc413

Saranya J, Saminathan P, Ankireddy SR, et al. Cerium oxide/graphene oxide hybrid: Synthesis, characterization, and evaluation of anti-cancer activity in a breast cancer cell line (MCF-7). Biomedicines. 2023;11(2):e531. https://doi.org/10.3390/biomedicines11020531

Naemi S, Meshkini A. Phytosynthesis of graphene oxide encapsulated selenium nanoparticles using Crocus sativus petals’ extract and evaluation of their bioactivity. J Drug Deliv Sci Technol. 2023;81:e104286. https://doi.org/10.1016/j.jddst.2023.104286

Liman R, Ilikci-Sagkan R, Istifli ES, et al. Preparation of graphene-based nanocomposites with spinel ferrite nanoparticles: their cytotoxic levels in different human cell lines and molecular docking studies. J Organomet Chem. 2023;990:e122660. https://doi.org/10.1016/j.jorganchem.2023.122660

Khan HA, Lee YK, Shaik MR, et al. Hybrid nanoparticles of manganese oxide and highly reduced graphene oxide for photodynamic therapy. Front Biosci. 2023;28(1):e19. https://doi.org/10.31083/j.fbl2801019

Deb A, Vimala R. Camptothecin loaded graphene oxide nanoparticle functionalized with polyethylene glycol and folic acid for anti-cancer drug delivery. J Drug Deliv Sci Technol. 2018;43:333–342. https://doi.org/10.1016/j.jddst.2017.10.025

Abdullah SS, Khaleel ZT, Jabir MS. Amygdalin and graphene oxide nanoparticles as a promising approach against the proliferation of breast cancer AMJ13 cells: in-vitro study. AIP Conf Proc. 2023;2414(1):e020017. https://doi.org/10.1063/5.0118331

Ramazani A, Abrvash M, Sadighian S, Rostamizadeh K, Fathi M. Preparation and characterization of curcumin-loaded gold/graphene oxide nanocomposite for potential breast cancer therapy. Res Chem Intermed. 2018;44:7891–7904. https://doi.org/10.1007/s11164-018-3593-8

Ghanbari N, Salehi Z, Khodadadi AA, Shokrgozar MA, Saboury AA. Glucosamine-conjugated graphene quantum dots as versatile and pH-sensitive nanocarriers for enhanced delivery of curcumin targeting to breast cancer. Mater Sci Eng C. 2021;121:e111809. https://doi.org/10.1016/j.msec.2020.111809

De D, Das CK, Mandal D, et al. Curcumin complexed with graphene derivative for breast cancer therapy. ACS Appl Bio Mater. 2020;3(9):6284–6296. https://doi.org/10.1021/acsabm.0c00771

Ribeiro BF, Souza MM, Fernandes DS, do Carmo DR, Machado‐Santelli GM. Graphene oxide‐based nanomaterial interaction with human breast cancer cells. J Biomed Mater Res A. 2020;108(4):863–870. https://doi.org/10.1002/jbm.a.36864

Motafeghi F, Gerami M, Mortazavi P, Khayambashi B, Ghassemi-Barghi N, Shokrzadeh M. Green synthesis of silver nanoparticles, graphene, and silver-graphene nanocomposite using Melissa officinalis ethanolic extract: anti-cancer effect on MCF-7 cell line. Iran J Basic Med Sci. 2023;26(1):57–68. https://doi.org/10.22038/IJBMS.2022.65503.14410

Dolatkhah M, Hashemzadeh N, Barar J, et al. Graphene-based multifunctional nanosystems for simultaneous detection and treatment of breast cancer. Colloids Surf B Biointerfaces. 2020;193:e111104. https://doi.org/10.1016/j.colsurfb.2020.111104

Liu J, Yuan X, Deng L, et al. Graphene oxide activated by 980 nm laser for cascading two-photon photodynamic therapy and photothermal therapy against breast cancer. Appl Mater Today. 2020;20:e100665. https://doi.org/10.1016/j.apmt.2020.100665

Wang L, Wang M, Zhou B, et al. PEGylated reduced-graphene oxide hybridized with Fe₃O₄ nanoparticles for cancer photothermal-immunotherapy. J Mater Chem B. 2019;7:7406–7414. https://doi.org/10.1039/C9TB00630C

Jang Y, Kim S, Lee S, Yoon CM, Lee I, Jang J. Graphene oxide wrapped SiO₂/TiO₂ hollow nanoparticles loaded with photosensitizer for photothermal and photodynamic combination therapy. Chem Eur J. 2017;23(15):3719–3727. https://doi.org/10.1002/chem.201605112

Alsaedi IIJ, Taqi ZJ, Hussien AMA, Sulaiman GM, Jabir MS. Graphene nanoparticles induce apoptosis in MCF-7 cells through mitochondrial damage and NF-κB pathway. Mater Res Express. 2019;6(9):e095413. https://doi.org/10.1088/2053-1591/ab33af

Li J, Liang X, Zhang J, et al. Inhibiting pulmonary metastasis of breast cancer based on dual-targeting graphene oxide with high stability and drug-loading capacity. Nanomedicine. 2018;14(4):1237–1248. https://doi.org/10.1016/j.nano.2018.02.012

Xu Q, Yuan H, Dong X, et al. Dual nanoenzyme modified microelectrode based on carbon fiber coated with AuPd alloy nanoparticles decorated graphene quantum dots assembly for electrochemical detection in clinic cancer samples. Biosens Bioelectron. 2018;107:153–162. https://doi.org/10.1016/j.bios.2018.02.026

Tade RS, Patil PO. Theranostic prospects of graphene quantum dots in breast cancer. ACS Biomater Sci Eng. 2020;6(11):5987–6008. https://doi.org/10.1021/acsbiomaterials.0c01045

Mirzaie V, Ansari M, Nematollahi-Mahani SN, et al. Nano-graphene oxide-supported APTES-spermine, as gene delivery system, for transfection of pEGFP-p53 into breast cancer cell lines. Drug Des Devel Ther. 2020;14:3087–3096. https://doi.org/10.2147/DDDT.S251005

de Melo-Diogo D, Costa EC, Alves GC, et al. POxylated graphene oxide nanomaterials for combination chemo-phototherapy of breast cancer cells. Eur J Pharm Biopharm. 2018;131:162–169. https://doi.org/10.1016/j.ejpb.2018.08.008

Rajaei M, Rashedi H, Yazdian F, Navaei-Nigjeh M, Rahdar A, Diez-Pascual AM. Chitosan/agarose/graphene oxide nanohydrogel as drug delivery system of 5-fluorouracil in breast cancer therapy. J Drug Deliv Sci Technol. 2023;82:e104307. https://doi.org/10.1016/j.jddst.2023.104307

Zare Y, Rhee KY, Park SJ. Simulating electrical conductivity of graphene-filled system by developing McLachlan model applicable to breast cancer biosensors. JOM. 2023;75:954–962. https://doi.org/10.1007/s11837-022-05686-2

Zare Y, Rhee KY. Multiphase approach for calculation of tunneling conductivity of graphene-polymer nanocomposites to optimize breast cancer biosensors. Compos Sci Technol. 2023;232:e109852. https://doi.org/10.1016/j.compscitech.2022.109852

Li X, Wang Y, Liu T, Zhang Y, Wang C, Xie B. Ultrasmall graphene oxide for combination of enhanced chemotherapy and photothermal therapy of breast cancer. Colloids Surf B Biointerfaces. 2023;225:e113288. https://doi.org/10.1016/j.colsurfb.2023.113288

Hatshan MR, Saquib Q, Siddiqui MA, et al. Effectiveness of nonfunctionalized graphene oxide nanolayers as nanomedicine against colon, cervical, and breast cancer cells. Int J Mol Sci. 2023;24(11):e9141. https://doi.org/10.3390/ijms24119141

Amraee N, Majd A, Torbati MB, Shaabanzadeh M. Folic acid-decorated and PEGylated graphene quantum dots as efficient tamoxifen delivery system against breast cancer cells: in vitro studies. Res Seq. https://doi.org/10.21203/rs.3.rs-2507864/v1

Chaudhari NS, Pandey AP, Patil PO, Tekade AR, Bari SB, Deshmukh PK. Graphene oxide based magnetic nanocomposites for efficient treatment of breast cancer. Mater Sci Eng C. 2014;37:278–285. https://doi.org/10.1016/j.msec.2014.01.007

Itoo AM, Vemula SL, Gupta MT, et al. Multifunctional graphene oxide nanoparticles for drug delivery in cancer. J Control Release. 2022;350:26–59. https://doi.org/10.1016/j.jconrel.2022.08.011

Shafiee A, Iravani S, Varma RS. Graphene and graphene oxide with anti-cancer applications: Challenges and future perspectives. MedComm. 2022;3(1):e118. https://doi.org/10.1002/mco2.118

Pourmadadi M, Dinani HS, Tabar FS, et al. Properties and applications of graphene and its derivatives in biosensors for cancer detection: a comprehensive review. Biosensors. 2022;12(5):e269. https://doi.org/10.3390/bios12050269

Veeresham C. Natural products derived from plants as a source of drugs. J Adv Pharm Technol Res. 2012;3(4):200–201. https://doi.org/10.4103/2231-4040.104709

Gurunathan S, Han JW, Park JH, Eppakayala V, Kim JH. Ginkgo biloba: a natural reducing agent for the synthesis of cytocompatible graphene. Int J Nanomed. 2014;9:363–377. https://doi.org/10.2147/IJN.S53538

Zhao X, Wei Z, Zhao Z, et al. Design and development of graphene oxide nanoparticle/chitosan hybrids showing pH-sensitive surface charge-reversible ability for efficient intracellular doxorubicin delivery. ACS Appl Mater Interf. 2018;10(7):6608–6617. https://doi.org/10.1021/acsami.7b16910

Weaver CL, LaRosa JM, Luo X, Cui XT. Electrically controlled drug delivery from graphene oxide nanocomposite films. ACS Nano. 2014;8(2):1834–1843. https://doi.org/10.1021/nn406223e

Wang X, Sun X, Lao J, et al. Multifunctional graphene quantum dots for simultaneous targeted cellular imaging and drug delivery. Colloids Surf B Biointerf. 2014;122:638–644. https://doi.org/10.1016/j.colsurfb.2014.07.043

Justin R, Tao K, Román S, et al. Photoluminescent and superparamagnetic reduced graphene oxide–iron oxide quantum dots for dual-modality imaging, drug delivery and photothermal therapy. Carbon. 2016;97:54–70. https://doi.org/10.1016/j.carbon.2015.06.070

Deng W, Qiu J, Wang S, et al. Development of biocompatible and VEGF-targeted paclitaxel nanodrugs on albumin and graphene oxide dual-carrier for photothermal-triggered drug delivery in vitro and in vivo. Int J Nanomed. 2018;13:439–453. https://doi.org/10.2147/IJN.S150977

Muthoosamy K, Abubakar IB, Bai RG, Loh HS, Manickam S. Exceedingly higher co-loading of curcumin and paclitaxel onto polymer-functionalized reduced graphene oxide for highly potent synergistic anti-cancer treatment. Sci Rep. 2016;6:e32808. https://doi.org/10.1038/srep32808

Chen K, Ling Y, Cao C, Li X, Chen X, Wang X. Chitosan derivatives/reduced graphene oxide/alginate beads for small-molecule drug delivery. Mater Sci Eng C. 2016;69:1222–1228. https://doi.org/10.1016/j.msec.2016.08.036

Zhang B, Yan Y, Shen Q, et al. A colon targeted drug delivery system based on alginate modificated graphene oxide for colorectal liver metastasis. Mater Sci Eng C. 2017;79:185–190. https://doi.org/10.1016/j.msec.2017.05.054

Rahmani Z, Sahraei R, Ghaemy M. Preparation of spherical porous hydrogel beads based on ion-crosslinked gum tragacanth and graphene oxide: study of drug delivery behavior. Carbohydr Polym. 2018;194:34–42. https://doi.org/10.1016/j.carbpol.2018.04.022

Jiang JH, Pi J, Jin H, Cai JY. Functional graphene oxide as cancer-targeted drug delivery system to selectively induce oesophageal cancer cell apoptosis. Artif Cells Nanomed Biotechnol. 2018;46(3):297–307. https://doi.org/10.1080/21691401.2018.1492418

Koyyada A, Orsu P. Safety and toxicity concerns of graphene and its composites. Compr Anal Chem. 2020;91:327–353. https://doi.org/10.1016/bs.coac.2020.08.011

Gu Z, Zhu S, Yan L, Zhao F, Zhao Y. Graphene-based smart platforms for combined cancer therapy. Adv Mater. 2018;31(9):se1800662. https://doi.org/10.1002/adma.201800662

Sengupta J, Hussain CM. Early detection of cancer utilizing biosensors based on “green graphene”: An innovative and sustainable methodology for advancing cancer diagnosis. TrAC Trends Anal Chem. 2023;167:e117254. https://doi.org/10.1016/j.trac.2023.117254

Shafiee A, Iravani S, Varma RS. Graphene and graphene oxide with anti-cancer applications: Challenges and future perspectives. MedComm. 2022;3(1):e118. https://doi.org/10.1002/mco2.118

Rhazouani A, Gamrani H, Gebrati L, et al. Synthesis and toxicity of graphene oxide nanoparticles: A literature review of in vitro and in vivo studies. Biomed Res Int. 2021;2021(1):e518999. https://doi.org/10.1155/2021/5518999

Rahimi S, van Leeuwen D, Roshanzamir F, et al. Ginsenoside Rg3 reduces the toxicity of graphene oxide used for pH-responsive delivery of doxorubicin to liver and breast cancer cells. Pharmaceutics. 2023;15(2):e391. https://doi.org/10.3390/pharmaceutics15020391

Mirzababaei M, Larijani K, Hashemi-Moghaddam H, et al. Graphene quantum dots coated cationic polymer for targeted drug delivery and imaging of breast cancer. J Polym Res. 2023;30:e268. https://doi.org/10.1007/s10965-023-03638-1

Published
2025-07-31
How to Cite
Younus, I., Siddiq, A., Khan, S. J., Mujeeb, N., & Sadaf, R. (2025). Therapeutic Potential of Graphene Nanoparticles in Breast Cancer: Insights from the Past Ten Years. Currents in Pharmaceutical Research, 3(1), 149-181. https://doi.org/10.32350/cpr.31.08
Section
Review Article